Regencell Bioscience Valuation
| RGC Stock | USD 25.07 3.31 11.66% |
At this time, the company appears to be fairly valued. Regencell Bioscience holds a recent Real Value of $29.09 per share. The prevailing price of the company is $25.07. Our model determines the value of Regencell Bioscience from analyzing the company fundamentals such as Return On Equity of -0.55, shares owned by institutions of 0.13 %, and Shares Outstanding of 494.49 M as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Regencell Bioscience's price fluctuation is slightly risky at this time. Calculation of the real value of Regencell Bioscience is based on 3 months time horizon. Increasing Regencell Bioscience's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Regencell Bioscience is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Regencell Stock. However, Regencell Bioscience's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 25.07 | Real 29.09 | Hype 23.99 | Naive 28.59 |
The real value of Regencell Stock, also known as its intrinsic value, is the underlying worth of Regencell Bioscience Company, which is reflected in its stock price. It is based on Regencell Bioscience's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Regencell Bioscience's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Regencell Bioscience Holdings helps investors to forecast how Regencell stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Regencell Bioscience more accurately as focusing exclusively on Regencell Bioscience's fundamentals will not take into account other important factors: About Regencell Bioscience Valuation
The stock valuation mechanism determines Regencell Bioscience's current worth on a weekly basis. Our valuation model uses a comparative analysis of Regencell Bioscience. We calculate exposure to Regencell Bioscience's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Regencell Bioscience's related companies.Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine bioscience company. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong. Regencell Bioscience operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 13 people.
Complementary Tools for Regencell Stock analysis
When running Regencell Bioscience's price analysis, check to measure Regencell Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regencell Bioscience is operating at the current time. Most of Regencell Bioscience's value examination focuses on studying past and present price action to predict the probability of Regencell Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regencell Bioscience's price. Additionally, you may evaluate how the addition of Regencell Bioscience to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |